South Africa's Aspen Pharmacare said ​on Monday that its Canadian subsidiary had received regulatory approval ​from Health ...

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

The first generic weight-loss GLP-1 injection Sevmia was recently approved by Health Canada. Here’s what you need to know.

Health Canada has approved the first generic semaglutide injection for weight loss.

Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

The arrival of generic semaglutide in India was expected to make obesity and diabetes treatment more affordable and ...

Emcure's semaglutide brand Poviztra has received CDSCO approval for treating MASH, expanding access to fatty liver treatment ...

As demand for injectable weight-loss medicines grows, experts are urging South Africans to check whether their medication is SAHPRA-registered, warning that unregistered products may carry serious ...

Sun Pharma receives SAHPRA approval to market a generic semaglutide injection for type 2 diabetes in South Africa.

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what's the difference? And which form is more effective for weight loss? Semaglutide ...

By Rishika Sadam and Kashish Tandon July 9 (Reuters) - India's Dr Reddy's Laboratories said on Thursday that supplies of its ...